<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    8023719
   </pmid>
   <datecreated>
    <year>
     1994
    </year>
    <month>
     08
    </month>
    <day>
     02
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1994
    </year>
    <month>
     08
    </month>
    <day>
     02
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2006
    </year>
    <month>
     11
    </month>
    <day>
     15
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0002-0729
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       23
      </volume>
      <issue>
       2
      </issue>
      <pubdate>
       <year>
        1994
       </year>
       <month>
        Mar
       </month>
      </pubdate>
     </journalissue>
     <title>
      Age and ageing
     </title>
     <isoabbreviation>
      Age Ageing
     </isoabbreviation>
    </journal>
    <articletitle>
     Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
    </articletitle>
    <pagination>
     <medlinepgn>
      121-6
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      Retrospective analyses of two multicentre clinical trials were carried out to examine the association of age with endoscopically verified reflux oesophagitis lesions and symptoms before and after 4 or, if necessary, 8 weeks randomized double-blind treatment with omeprazole (20 mg o.m.) or histamine H2-receptor antagonists (H2RA) (cimetidine 400 mg q.d.s. or ranitidine 150 mg b.d.). Of the elderly patients (&gt; or = 65 years) 79 received omeprazole, 39 cimetidine and 36 ranitidine; of the young patients (&lt; 65 years) 200 received omeprazole, 94 cimetidine and 102 ranitidine. The objective of treatment was to heal the oesophagus and to relieve the patient's symptoms. On completion of the studies the proportion of elderly omeprazole-treated patients (68%) healed and symptom-free was nearly three times that of elderly H2RA-treated patients (23%, p &lt; 0.001). In the young patient group the proportion of omeprazole-treated patients (57%) both healed and symptom-free was nearly twice that of H2RA-treated patients (29%, p &lt; 0.001). The advantage of omeprazole over H2RA, in terms of endoscopic healing and symptom relief, is at least as great in elderly patients as in younger patients.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Geriatric Medicine, University of Newcastle upon Tyne, School of Clinical Medical Sciences.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       James
      </lastname>
      <forename>
       O F
      </forename>
      <initials>
       OF
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Parry-Billings
      </lastname>
      <forename>
       K S
      </forename>
      <initials>
       KS
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Comparative Study
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Multicenter Study
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     ENGLAND
    </country>
    <medlineta>
     Age Ageing
    </medlineta>
    <nlmuniqueid>
     0375655
    </nlmuniqueid>
    <issnlinking>
     0002-0729
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      51481-61-9
     </registrynumber>
     <nameofsubstance>
      Cimetidine
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      66357-35-5
     </registrynumber>
     <nameofsubstance>
      Ranitidine
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      73590-58-6
     </registrynumber>
     <nameofsubstance>
      Omeprazole
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="CommentIn">
     <refsource>
      ACP J Club. 1994 Nov-Dec;121(3):64-6
     </refsource>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged, 80 and over
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cimetidine
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Dose-Response Relationship, Drug
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Double-Blind Method
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Drug Administration Schedule
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Esophagitis, Peptic
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      pathology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Esophagoscopy
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Follow-Up Studies
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Omeprazole
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Ranitidine
     </descriptorname>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Treatment Outcome
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Wound Healing
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
   </meshheadinglist>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1994
     </year>
     <month>
      3
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1994
     </year>
     <month>
      3
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1994
     </year>
     <month>
      3
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     8023719
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

